Bahrain, First in the Middle East to Acquire Latest Machine used for Human Genome Sequencing

November 29, 2023 08:52 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

MANAMA, Bahrain, Nov. 29, 2023 /PRNewswire/ -- The Ministry of Health in the Kingdom of Bahrain has become the first in the Middle East to acquire and inaugurate the use of the cutting-edge NovaSeqTM X Plus machine for human genome sequencing purposes. The move is part of the Kingdom's commitment to continue developing therapeutic and diagnostic services in line with latest global medical advancements, benefiting the health of all.

The Chairman of the Supreme Council of Health, Lt. General Dr. Shaikh Mohammed bin Abdulla Al Khalifa, highlighted the ongoing efforts within the National Genome Project, which aims to utilize gene sequencing in adopting effective national health policies and therapeutic and preventative management plans.

For her part, the Minister of Health, Dr. Jaleela bint Al-Sayed Jawad Hassan noted that acquiring this device is in line with continuing efforts to keep abreast of latest technological trends in the health field, while further developing the National Genome Centre, which will reflect positively on the various diagnostic and therapeutic services in place for the benefit of the community.

Meanwhile, Dr. Gregory Essert, General Manager of Emerging Markets at Illumina, stated, "Through our latest specialized device in genome sequencing, NovaSeqTM X Plus, we can generate more than 20,000 whole genomes per year – 2.5 times our previous capacity, we look forward to contributing to the National Genome Centre's goal in the Kingdom of Bahrain by employing technology to gain a better understanding of diseases and potential genetic risks, thereby developing healthcare plans."

Likewise, Mr Abdelrahman Ramadan, the Chief Executive *officer* of Zahrawi Group who's the local representative of Illumina in Bahrain has emphasized, "We believe that the

Bahrain National Genome Project, in tandem with Zahrawi Group's vision and mission, symbolizes a significant step towards achieving excellence in genomics research, fostering trust, and making meaningful contributions to the well-being of people in the GCC region and beyond".

It is worth mentioning that the National Genome Project was launched in the Kingdom of Bahrain in 2019, and awareness campaigns have been initiated by public health institutions to encourage community participation in the program, with a target of collecting 50,000 samples by 2024.

A national delegation of specialists from the National Genome Centre was sent to Harvard University in the United States to undergo specialized training, including the latest methods of genome sequencing, biological data classification, clinical analysis, scientific data analysis, and genetic data management.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.